Johnson & Johnson CEO Change After 10 Years... CEO Goski to Step Down in January Next Year
The Successor is Vice Chairman Joaquin Duato
[Asia Economy Reporter Kwon Jae-hee] Alex Gorsky, CEO of the American pharmaceutical company Johnson & Johnson (J&J), will step down in January next year. Joaquin Duato, Vice Chairman, is expected to take over as the new CEO.
According to CNBC on the 9th (local time), Gorsky, who has led Johnson & Johnson for nine years since 2012, will step down as CEO on January 3rd next year. Gorsky plans to serve as chairman of the board after stepping down as CEO.
In a statement, CEO Gorsky explained, "For personal reasons related to family health, now is the right time for me to focus more on my family."
During Gorsky's leadership, Johnson & Johnson faced class-action lawsuits related to baby powder and also experienced the opioid abuse crisis. Last month, opioid distributors and Johnson & Johnson agreed to pay $26 billion (approximately 30 trillion won) in settlement.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Johnson & Johnson's COVID-19 vaccine received approval from the U.S. Food and Drug Administration (FDA) at the end of February. Subsequently, the FDA added a warning label in April about the possibility of blood clot side effects, and in July, Guillain-Barr? syndrome was reported to have occurred very rarely.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
